Levere (LVRA) 10-Q 9 Jul 21 2021 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2021	Jul. 07, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	Levere Holdings Corp.
Entity Central Index Key	0001841383
Amendment Flag	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Document Period End Date	Mar. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	E9
Current Fiscal Year End Date	--12-31
Entity Shell Company	true
Entity Address, State or Province	KY
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	LVRA
Security Exchange Name	NASDAQ
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Trading Symbol	LVRAU
Security Exchange Name	NASDAQ
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	LVRAW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		27,128,532
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,655,368

Condensed Balance Sheet

Condensed Balance Sheet	Mar. 31, 2021USD ($)
Assets:
Cash	$ 1,662,766
Prepaid Expenses	403,525
Total current assets	2,066,291
Other assets	319,639
Cash and investments held in Trust Account	271,285,654
Total Assets	273,671,584
Liabilities and Shareholders' Equity
Accrued offering costs and expenses	1,212,517
Due to related party	2,581
Total current liabilities	1,215,098
Deferred underwriting fee	9,494,986
Warrant liability	16,701,548
Total liabilities	27,411,632
Commitments and Contingencies
Class A Ordinary shares subject to possible redemption, 24,125,995 shares at redemption value	241,259,950
Shareholders' Equity:
Preferred share, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding	0
Additional paid-in capital	5,799,795
Accumulated deficit	(800,759)
Total shareholders' equity	5,000,002
Total Liabilities and Shareholders' Equity	273,671,584
Common Class A [Member]
Shareholders' Equity:
Common stock par value	300
Common Class B [Member]
Shareholders' Equity:
Common stock par value	$ 666

Condensed Balance Sheet (Parent

Condensed Balance Sheet (Parenthetical)	Mar. 31, 2021$ / sharesshares
Preferred stock par or stated value per share | $ / shares	$ 0.0001
Preferred stock shares authorized	5,000,000
Preferred stock shares issued	0
Preferred stock shares outstanding	0
Common Class A [Member]
Temporary equity shares outstanding	24,125,995
Common stock par or stated value per share | $ / shares	$ 0.0001
Common stock shares authorized	500,000,000
Common stock shares issued	3,002,537
Common stock shares outstanding	3,002,537
Common Class B [Member]
Common stock par or stated value per share | $ / shares	$ 0.0001
Common stock shares authorized	50,000,000
Common stock shares issued	6,655,368
Common stock shares outstanding	6,655,368

Condensed Statement of Operatio

Condensed Statement of Operations	3 Months Ended
	Mar. 31, 2021USD ($)$ / sharesshares
Formation and operating costs	$ 52,688
Loss from Operations	(52,688)
Other income:
Interest earned on cash and marketable securities held in Trust Account	334
Offering costs allocated to warrants	(618,405)
Change in fair value of warrant liability	(130,000)
Total other income (expense)	(748,071)
Net loss	$ (800,759)
Redeemable Class A Common Stock [Member]
Other income:
Weighted average shares outstanding | shares	23,809,201
Basic and diluted net income loss per ordinary share | $ / shares	$ 0
Nonredeemable Class A And Class B Common Stock [Member]
Other income:
Weighted average shares outstanding | shares	6,434,043
Basic and diluted net income loss per ordinary share | $ / shares	$ (0.12)

Condensed Statement of Changes

Condensed Statement of Changes in Shareholders' Equity - 3 months ended Mar. 31, 2021 - USD ($)	Total	Common Stock [Member]Common Class A [Member]	Common Stock [Member]Common Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Members]
Beginning Balance at Jan. 14, 2021	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning Balance (in Shares) at Jan. 14, 2021		0	0
Class B ordinary shares issued to Sponsor	25,000		$ 719	24,281
Class B ordinary shares issued to Sponsor (in Shares)			7,187,500
Sale of 27,128,532 Units, net of offering expenses related to Class A ordinary shares and initial fair value of Public Warrants	245,503,904	$ 2,713		245,501,191
Sale of 27,128,532 Units, net of offering expenses related to Class A ordinary shares and initial fair value of Public Warrants (in Shares)		27,128,532
Excess Private Placement proceeds received over initial fair value of Private Placement Warrants	1,531,807			1,531,807
Forfeiture of Class B ordinary shares by initial shareholders			$ (53)	53
Forfeiture of Class B ordinary shares by initial shareholders (in Shares)			(532,132)
Net loss	(800,759)				(800,759)
Ordinary shares subject to possible redemption	(241,259,950)	$ (2,413)		(241,257,537)
Ordinary shares subject to possible redemption (in Shares)		(24,125,995)
Ending Balance at Mar. 31, 2021	$ 5,000,002	$ 300	$ 666	$ 5,799,795	$ (800,759)
Ending Balance (in Shares) at Mar. 31, 2021		3,002,537	6,655,368

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows	3 Months Ended
	Mar. 31, 2021USD ($)
Cash flows from operating activities:
Net loss	$ (800,759)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investments held in trust account	(334)
Offering costs allocated to warrants	618,405
Change in fair value of warrant liability	130,000
Changes in operating assets and liabilities:
Prepaid expenses	(403,525)
Other assets	(319,639)
Accrued expenses	712,808
Due to related party	2,581
Net cash used in operating activities	(60,463)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(271,285,320)
Net cash used in investing activities	(271,285,320)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B ordinary shares to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discount	265,859,614
Proceeds from sale of Private Placement Warrants	7,425,706
Proceeds from promissory note related party	211,135
Payments of promissory note related party	(211,135)
Payment of offering costs	(301,771)
Net cash provided by financing activities	273,008,549
Net change in cash	1,662,766
Cash, beginning of period	0
Cash, end of the period	1,662,766
Supplemental disclosure of cash flow information:
Initial classification of ordinary shares subject to possible redemption	241,259,950
Deferred underwriters' discount payable charged to additional paid-in capital	$ 9,494,986

Organization and Business Opera

Organization and Business Operations	3 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operations	Note 1 — Organization and Business Operations Levere Holdings Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on January 15, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses or entities (the “Business Combination”). As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation and the Initial Public Offering (“IPO”) which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating The Company’s sponsor was Levere Holding GG Ltd. (“Levere GG”), a U.K private company limited by shares. On March 23, 2021, the Company entered into an agreement with Goggo Network GmbH, a German company limited by shares and Levere GG, pursuant to which Levere GG transferred 6,413,571 Class B ordinary shares it holds in the Company to Goggo Network Gmbh. Upon the transfer of shares, Goggo Network Gmbh became the new sponsor of the Company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on March 18, 2021. On March 23, 2021, the Company consummated the IPO of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250,000,000, which is discussed in Note 4. Each Unit consists of one Class A ordinary share, and one-third Simultaneously with the closing of the IPO, the Company consummated the issuance and sale of 4,666,667 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $7,000,000, which is discussed in Note 5 (the “IPO Private Placement”). On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units, generating an aggregate of gross proceeds of $21,285,320, incurred $425,706 in cash underwriting fees, and forfeited the remainder of the option. Simultaneously with the closing of the exercise of the over-allotment option, the Company completed the sale of an additional 283,804 Private Placement Warrants to the Sponsor, at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds of $425,706, which is discussed in Note 5 (the “Over-Allotment Private Placement”, and together with the IPO Private Placement, the “Private Placements”). Transaction costs of the IPO and the over-allotment option amounted to $15,722,172 consisting of $5,425,706 of underwriting discount, $9,494,986 of deferred underwriting discount, and $801,480 of other offering costs of which $618,405 were allocated to expense associated with the warrant liability. Following the closing of the IPO on March 23, 2021, and closing of the over-allotment option on March 31, 2021, $271,285,320 ($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and over-allotment, and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested only in U.S. government treasury obligations with a maturity of 185 under Rule 2a-7 under the 24 The Company will provide shareholders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination at a per-share price, payable The Company will have 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares (as defined below), (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame), and (iv) vote their Founder Shares and Public Shares in favor of the Company’s initial Business Combination. Liquidity and Capital Resources As of March 31, 2021, the Company had approximately $1.7 million in its operating bank account, and working capital of approximately $1.2 million. The Company’s liquidity needs up to March 23, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 6) for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 6). Subsequent to the consummation of the IPO, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placements not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the officers and directors may, but are not obligated to, provide the Company with working capital loans. As of March 31, 2021, there were no amounts outstanding under any working capital loan. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from the adte of this filing. Over this time period, the Company will be using these funds held outside of the Trust Account to pay existing accounts payable, identify and evaluate prospective initial Business Combination candidates, perform due diligence on prospective initial Business Combination candidates, pay for travel expenditures, and structure, negotiate and consummate the Business Combination. Risks and Uncertainties The Company’s management is continuing to evaluate the impact of the COVID-19

Revision of Previously Issued F

Revision of Previously Issued Financial Statements	3 Months Ended
	Mar. 31, 2021
Accounting Changes and Error Corrections [Abstract]
Revision of Previously Issued Financial Statements	Note 2 — Revision of Previously Issued Financial Statements On April 12, 2021, the staff of the Securities and Exchange Commission (the “Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “Staff Statement”). In the Staff Statement, the Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheet,based on our application of Accounting Standards Codification (“ASC”) 815-40, 815-40”). 815-40 Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued balance sheet as of March 23, 2021, should be revised because of a misapplication in the guidance around accounting for certain of our outstanding warrants to purchase ordinary shares. As such, the Company is revising its March 23, 2021 balance sheet included in this Quarterly Report Impact of the Revision The impact to the balance sheet dated March 23, 2021, filed on Form 8-K As of March 23, 2021 As Previously Revision As Revised Total assets $ 252,574,683 $ — $ 252,574,683 Liabilities and shareholders’ equity: Total current liabilities $ 1,128,657 $ — $ 1,128,657 Deferred underwriting fee 8,750,000 — 8,750,000 Warrant liabilities — 15,386,666 15,386,666 Total liabilities 9,878,657 15,386,666 25,265,323 Class A ordinary shares, $0.0001 par value; share subject to possible redemption 237,696,020 (15,386,666 ) 222,309,354 Shareholders’ equity Preference share - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 123 154 277 Class B ordinary shares - $0.0001 par value 719 — 719 Additional paid-in-capital 5,036,925 561,967 5,598,892 Accumulated deficit (37,761 ) (562,121 ) (599,882 ) Total shareholders’ equity 5,000,006 — 5,000,006 Total liabilities and shareholders’ equity $ 252,574,683 $ — $ 252,574,683

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 3 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933 (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not h ave any cash equivalents as of March 31, 2021 . Marketable Securities Held in Trust Account At March 31, 2021, substantially all of the assets held in the Trust Account were held in cash to be invested in money market funds which invest U.S. Treasury securiti es. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 9,042,843 (4,950,471) Wa rrant Liabilities The Company evaluated the Warrants, which are discussed in Note 2, Note 4, Note 5 and Note 9, in accordance with ASC 815-40 815-40, Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1, non-operating Ordinary shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Income Taxes ASC 740 “Accounting for Income Tax” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company applies the two-class Reconciliation of Net Loss per Share The Company’s net loss is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic per Non-redeemable Three Months Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest earned on marketable securities held in Trust Account $ 334 Less: Interest allocable of to Non-Redeemable Class A Ordinary Shares (37 ) Net income allocable to shares subject to possible redemption $ 297 Denominator: Weighted Average Redeemable Class A Ordinary Shares Basic and diluted weighted average shares outstanding 23,809,201 Basic and diluted net income per share $ 0.00 Non-Redeemable Class A and Class B Ordinary Shares Numerator: Net Loss Minus Net Earnings Net loss $ (800,759 ) Less: Income attributable to ordinary shares subject to possible redemption (297 ) Non-Redeemable net loss $ (801,056 ) Weighted average non-redeemable shares outstanding, basic and diluted 6,434,043 Basic and diluted net loss per share $ (0.12 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Fair Value of Financial Instruments The fair value of the Company’s cash, prepaid expenses, other assets, accrued offering costs and expenses, and due to related party, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2021
Initial Public Offering [Abstract]
Initial Public Offering	Note 4 — Initial Public Offering Public Units On March 23, 2021, the Company sold 25,000,000 Units, at a purchase price of $10.00 per Unit, generating gross proceeds of $250,000,000. The Company granted the underwriters in the IPO (the “Underwriters”) a 45-day one-third one Public Warrants Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Public Warrants will become exercisable at $11.50 per share 30 days after the completion of the initial Business Combination. Only a whole Warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the Units and only whole Warrants will trade. The Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than 30 calendar days after the closing of the initial Business Combination, it will use commercially reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of its initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the Warrants expire or are redeemed, as specified in the Warrant Agreement; provided that if our Class A ordinary shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the Warrants is not effective by the 60th day after the closing of the initial Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not effective for the exercised Warrants, the purchaser of a unit containing such Warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20-trading days within a 30-trading day period Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares, as defined below; • if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading day • if the closing price of the Class A ordinary shares for any 20-trading days within a 30-trading day period The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume weighted average price of the Company’s Class A ordinary shares during the 10-trading days immediately In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

Private Placement

Private Placement	3 Months Ended
	Mar. 31, 2021
Private Placement [Abstract]
Private Placement	Note 5 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 4,666,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,000,000, in a private placement. Simultaneously with the closing of the exercise of the overallotment option, the Company completed the sale of an additional 283,804 Private Placement Warrants to the Sponsor, at a purchase price of $1.50 per Private Warrant, generating gross proceeds of $425,706. A portion of the proceeds from the sales of Private Placement Warrants were added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination. The Private Placement Warrants will be non-redeemable by the

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 — Related Party Transactions Founder Shares On January 19, 2021, the Sponsor purchased 7,187,500 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”) for $25,000, or approximately $0.003 per share, paid to cover certain offering costs. On March 15, 2021, the Company entered into an agreement with Goggo Network GmbH, a German company limited by shares and Levere GG, pursuant to which the Levere GG transferred 6,413,571 Class B ordinary shares it holds in the Company to Goggo Network Gmbh. Upon the transfer of shares, Goggo Network Gmbh became the new sponsor of the Company. Up to 937,500 Founder Shares were subject to forfeiture by the Sponsor, depending on the extent to which the Underwriters’ over-allotment option was exercised. On March 31, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,128,532 Units, and forfeited the remainder of the option. On March 31, 2021, the Sponsor surrendered to the Company for cancellation, 532,132 Class B ordinary shares. The Sponsor, directors and executive officers have agreed not to transfer, assign or sell any of their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period property (the “Lock-up”). Any permitted Due to Related Party Commencing on March 23, 2021, the Company agreed to reimburse the Sponsor or an affiliate of the Sponsor for office space, secretarial administrative and other support services provided to members of the management team, in the amount of up to $10,000 per month. Upon completion of the initial Business Combination or the Company’s liquidation, it will cease paying these monthly fees. A total of $2,581 has been accrued as of March 31, 2021. Promissory Note — Related Party On January 19, 2021, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan is non-interest bearing Working Capital Loans In addition, in order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may, at the option of the lender, be converted into Private Placement Warrants at a price of $1.50 per warrant. Such warrants would be identical to the Private Placement Warrants. Except as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of the initial Business Combination, the Company does not expect to seek loans from parties other than the Sponsor, its affiliates or any members of the management team as the Company does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Company’s Trust Account. As of March 31, 2021, the Company had no borrowings under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 7 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants, and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement entered into in connection with the IPO (the “Registration Rights Agreement”). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of an initial Business Combination. However, the Registration Rights Agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable Lock-up period, which Our Sponsor and our directors and executive officers have agreed not to transfer, assign or sell their founder shares until the earliest of (A) one year after the completion of our initial business combination; and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20-trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. Underwriting Agreement The Company granted the Underwriters a 45-day On March 23, 2021, the Company paid an underwriting discount of $5,000,000, and on March 31, 2021, the Company paid an additional underwriting discount of $425,706 for Units sold pursuant to the over-allotment option. Additionally, the Underwriters are entitled to deferred underwriting fee of 3.5% of the gross proceeds of the IPO and over-allotment, or $9,494,986 in the aggregate. The deferred fee will become payable to the Underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2021
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Note 8 — Shareholders’ Equity Preference Shares Class A Ordinary shares Class B Ordinary shares Holders of the Class A ordinary shares and holders of the Class B ordinary shares vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law. Unless specified in the Company’s amended and restated certificate of incorporation or as required applicable provisions of the Companies Act (2021 Revision) of the Cayman Islands or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least two-thirds of the The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) prior to, at the time of, or after its initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% less than one-to-one.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9 — Fair Value Measurements The Company follows the guidance in ASC 820 , “Fair Value Measurement”, for its financial assets and liabilities that are re-measured non-financial re-measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, Quoted Significant Significant Assets: Cash $ 21,285,320 $ 21,285,320 $ — $ — U.S. Money Market held in Trust Account 250,000,334 250,000,334 — — $ 271,285,654 $ 271,285,654 $ — $ — Liabilities: Public Warrants Liability $ 10,760,983 — — $ 10,760,983 Private Placement Warrants Liability 5,940,565 — — 5,940,565 $ 16,701,548 $ — $ — $ 16,701,548 The Warrants are accounted for as liabilities in accordance with ASC 815-40 The Company established the initial fair value of the Public Warrants and Private Placement Warrants on March 23, 2021, the date of the Company’s IPO, and as of March 31, 2021 for the overallotment, using a Monte Carlo simulation model. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The following table presents the changes Level 3 liabilities: Fair Value at January 15, 2021 (inception) $ — Initial fair value of public and private warrants 15,386,666 Initial fair value of public and private warrants issued with over-allotment 1,184,882 Change in fair value of public and private warrants 130,000 Fair Value at March 31, 2021 $ 16,701,548 The key inputs into the Monte Carlo simulation as of March 23, 2021 and March 31, 2021 were as follows: Inputs (Initial Measurement) March 31, 2021 Risk-free interest rate 1.06 % 1.16 % Expected term remaining (years) 6.00 6.00 Expected volatility 15.0 % 14.8 % Share price $ 9.61 $ 9.56

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933 (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not h ave any cash equivalents as of March 31, 2021 .
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At March 31, 2021, substantially all of the assets held in the Trust Account were held in cash to be invested in money market funds which invest U.S. Treasury securiti es.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 9,042,843 (4,950,471)
Warrant Liabilities	Wa rrant Liabilities The Company evaluated the Warrants, which are discussed in Note 2, Note 4, Note 5 and Note 9, in accordance with ASC 815-40 815-40,
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1, non-operating
Ordinary shares Subject to Possible Redemption	Ordinary shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets.
Income Taxes	Income Taxes ASC 740 “Accounting for Income Tax” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Loss Per Share	Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company applies the two-class
Reconciliation of Net Loss per Share	Reconciliation of Net Loss per Share The Company’s net loss is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic per Non-redeemable Three Months Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest earned on marketable securities held in Trust Account $ 334 Less: Interest allocable of to Non-Redeemable Class A Ordinary Shares (37 ) Net income allocable to shares subject to possible redemption $ 297 Denominator: Weighted Average Redeemable Class A Ordinary Shares Basic and diluted weighted average shares outstanding 23,809,201 Basic and diluted net income per share $ 0.00 Non-Redeemable Class A and Class B Ordinary Shares Numerator: Net Loss Minus Net Earnings Net loss $ (800,759 ) Less: Income attributable to ordinary shares subject to possible redemption (297 ) Non-Redeemable net loss $ (801,056 ) Weighted average non-redeemable shares outstanding, basic and diluted 6,434,043 Basic and diluted net loss per share $ (0.12 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s cash, prepaid expenses, other assets, accrued offering costs and expenses, and due to related party, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Revision of Previously Issued_2

Revision of Previously Issued Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2021
Accounting Changes and Error Corrections [Abstract]
Summary of prior period adjustments	As of March 23, 2021 As Previously Revision As Revised Total assets $ 252,574,683 $ — $ 252,574,683 Liabilities and shareholders’ equity: Total current liabilities $ 1,128,657 $ — $ 1,128,657 Deferred underwriting fee 8,750,000 — 8,750,000 Warrant liabilities — 15,386,666 15,386,666 Total liabilities 9,878,657 15,386,666 25,265,323 Class A ordinary shares, $0.0001 par value; share subject to possible redemption 237,696,020 (15,386,666 ) 222,309,354 Shareholders’ equity Preference share - $0.0001 par value — — — Class A ordinary shares - $0.0001 par value 123 154 277 Class B ordinary shares - $0.0001 par value 719 — 719 Additional paid-in-capital 5,036,925 561,967 5,598,892 Accumulated deficit (37,761 ) (562,121 ) (599,882 ) Total shareholders’ equity 5,000,006 — 5,000,006 Total liabilities and shareholders’ equity $ 252,574,683 $ — $ 252,574,683

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Summary of earnings per share, basic and diluted	Accordingly, basic per Non-redeemable Three Months Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest earned on marketable securities held in Trust Account $ 334 Less: Interest allocable of to Non-Redeemable Class A Ordinary Shares (37 ) Net income allocable to shares subject to possible redemption $ 297 Denominator: Weighted Average Redeemable Class A Ordinary Shares Basic and diluted weighted average shares outstanding 23,809,201 Basic and diluted net income per share $ 0.00 Non-Redeemable Class A and Class B Ordinary Shares Numerator: Net Loss Minus Net Earnings Net loss $ (800,759 ) Less: Income attributable to ordinary shares subject to possible redemption (297 ) Non-Redeemable net loss $ (801,056 ) Weighted average non-redeemable shares outstanding, basic and diluted 6,434,043 Basic and diluted net loss per share $ (0.12 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Summary of assets and liabilities that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, Quoted Significant Significant Assets: Cash $ 21,285,320 $ 21,285,320 $ — $ — U.S. Money Market held in Trust Account 250,000,334 250,000,334 — — $ 271,285,654 $ 271,285,654 $ — $ — Liabilities: Public Warrants Liability $ 10,760,983 — — $ 10,760,983 Private Placement Warrants Liability 5,940,565 — — 5,940,565 $ 16,701,548 $ — $ — $ 16,701,548
Summary of change in the fair value of the level 3 liabilities	The following table presents the changes Level 3 liabilities: Fair Value at January 15, 2021 (inception) $ — Initial fair value of public and private warrants 15,386,666 Initial fair value of public and private warrants issued with over-allotment 1,184,882 Change in fair value of public and private warrants 130,000 Fair Value at March 31, 2021 $ 16,701,548
Summary of fair value measurement inputs and valuation techniques	The key inputs into the Monte Carlo simulation as of March 23, 2021 and March 31, 2021 were as follows: Inputs (Initial Measurement) March 31, 2021 Risk-free interest rate 1.06 % 1.16 % Expected term remaining (years) 6.00 6.00 Expected volatility 15.0 % 14.8 % Share price $ 9.61 $ 9.56

Organization and Business Ope_2

Organization and Business Operations - Additional Information (Detail) - USD ($)	Mar. 31, 2021	Mar. 23, 2021	Mar. 15, 2021	Mar. 31, 2021
Proceeds from issuance of IPO				$ 265,859,614
Proceeds from issuance of private placement				7,425,706
Underwriting expense paid				425,706
Deferred underwriting fee noncurrent	$ 9,494,986			9,494,986
Offering costs allocated to warrants				618,405
Payment to acquire restricted investments				$ 271,285,320
Lock in period for redemption of public shares after closing of IPO				24 months
Restricted investments term				185 days
Stock Issued during period, value, new issues				$ 245,503,904
Dissolution Expense				$ 100,000
Percentage of public shares to be redeemed on non completion of business combination	100.00%			100.00%
Cash	$ 1,662,766			$ 1,662,766
Proceeds from issuance of common stock				25,000
Due to related parties current	2,581			2,581
Working capital (deficit)	$ 1,200,000			$ 1,200,000
Public Warrants [Member]
Exercise price of warrant	$ 11.50			$ 11.50
Private Placement Warrants [Member]
Exercise price of warrant	$ 10			$ 10
Class of warrants and rights issued during the period				4,666,667
Class of warrants and rights issued, price per warrant				$ 1.50
Proceeds from issuance of private placement				$ 7,000,000
IPO [Member]
Payment to acquire restricted investments				$ 271,285,320
Over-Allotment Option [Member]
Stock issued during period shares	2,128,532	3,750,000		2,128,532
Underwriting expense paid				$ 5,425,706
Transaction costs of IPO				15,722,172
Deferred underwriting fee noncurrent	$ 9,494,986			9,494,986
Other offering costs				801,480
Offering costs allocated to warrants				618,405
Stock Issued during period, value, new issues				21,285,320
Sponsor [Member]
Proceeds from issuance of common stock				25,000
Sponsor [Member] | Working Capital Loan [Member]
Proceeds from unsecured and non-interest bearing promissory note				300,000
Due to related parties current	$ 0			$ 0
Sponsor [Member] | Private Placement Warrants [Member]
Class of warrants and rights issued during the period				283,804
Class of warrants and rights issued, price per warrant				$ 1.50
Proceeds from issuance of private placement				$ 425,706
Common Class A [Member]
Stock conversion basis				one-third of one redeemable warrant to purchase one Class A ordinary share
Common Class A [Member] | Public Warrants [Member]
Shares issuable per warrant	1	1		1
Exercise price of warrant	$ 11.50	$ 11.50		$ 11.50
Common Class A [Member] | Public shares [Member]
Share price	10			10
Common Class A [Member] | IPO [Member]
Stock issued during period shares		25,000,000
Share price		$ 10
Proceeds from issuance of IPO		$ 250,000,000
Shares issued, price per share	$ 0.0001			$ 0.0001
Common Class A [Member] | Sponsor [Member]
Stock issued during period shares			6,413,571
Common Class B [Member] | Sponsor [Member]
Stock issued during period shares		6,413,571

Revision of Previously Issued_3

Revision of Previously Issued Financial Statements - Summary of Prior Period Adjustments (Detail) - USD ($)	Mar. 31, 2021	Mar. 23, 2021	Jan. 14, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Assets	$ 273,671,584
Total current liabilities	1,215,098
Deferred underwriting fee	9,494,986
Warrant liability	16,701,548
Total liabilities	27,411,632
Class A ordinary shares, $0.0001 par value; share subject to possible redemption	241,259,950
Shareholders' Equity:
Preferred stock par value	0
Additional paid-in capital	5,799,795
Accumulated deficit	(800,759)
Stockholders' Equity	5,000,002		$ 0
Total Liabilities and Shareholders' Equity	273,671,584
Common Class A [Member]
Shareholders' Equity:
Common stock par value	300
Common Class B [Member]
Shareholders' Equity:
Common stock par value	$ 666
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Assets		$ 252,574,683
Total current liabilities		1,128,657
Deferred underwriting fee		8,750,000
Total liabilities		9,878,657
Class A ordinary shares, $0.0001 par value; share subject to possible redemption		237,696,020
Shareholders' Equity:
Preferred stock par value
Additional paid-in capital		5,036,925
Accumulated deficit		(37,761)
Stockholders' Equity		5,000,006
Total Liabilities and Shareholders' Equity		252,574,683
As Previously Reported | Common Class A [Member]
Shareholders' Equity:
Common stock par value		123
As Previously Reported | Common Class B [Member]
Shareholders' Equity:
Common stock par value		719
Revision Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Warrant liability		15,386,666
Total liabilities		15,386,666
Class A ordinary shares, $0.0001 par value; share subject to possible redemption		(15,386,666)
Shareholders' Equity:
Preferred stock par value
Additional paid-in capital		561,967
Accumulated deficit		(562,121)
Revision Adjustment | Common Class A [Member]
Shareholders' Equity:
Common stock par value		154
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Assets		252,574,683
Total current liabilities		1,128,657
Deferred underwriting fee		8,750,000
Warrant liability		15,386,666
Total liabilities		25,265,323
Class A ordinary shares, $0.0001 par value; share subject to possible redemption		222,309,354
Shareholders' Equity:
Preferred stock par value
Additional paid-in capital		5,598,892
Accumulated deficit		(599,882)
Stockholders' Equity		5,000,006
Total Liabilities and Shareholders' Equity		252,574,683
As Revised | Common Class A [Member]
Shareholders' Equity:
Common stock par value		277
As Revised | Common Class B [Member]
Shareholders' Equity:
Common stock par value		$ 719

Revision of Previously Issued_4

Revision of Previously Issued Financial Statements - Summary of Prior Period Adjustments (Parenthetical) (Detail) - $ / shares	Mar. 31, 2021	Mar. 23, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Preferred stock par or stated value per share	$ 0.0001
Common Class A [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock par or stated value per share	0.0001
Common Class B [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock par or stated value per share	$ 0.0001
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Preferred stock par or stated value per share		$ 0.0001
As Previously Reported | Common Class A [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Temporary equity, par or stated value per share		0.0001
Common stock par or stated value per share		0.0001
As Previously Reported | Common Class B [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock par or stated value per share		0.0001
Revision Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Preferred stock par or stated value per share		0.0001
Revision Adjustment | Common Class A [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Temporary equity, par or stated value per share		0.0001
Common stock par or stated value per share		0.0001
Revision Adjustment | Common Class B [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock par or stated value per share		0.0001
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Preferred stock par or stated value per share		0.0001
As Revised | Common Class A [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Temporary equity, par or stated value per share		0.0001
Common stock par or stated value per share		0.0001
As Revised | Common Class B [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock par or stated value per share		$ 0.0001

Revision of Previously Issued_5

Revision of Previously Issued Financial Statements - Additional Information (Detail) - Revision of Prior Adjustment [Member]	Mar. 23, 2021USD ($)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Increase in warrant liabilities	$ 15,400,000
Transaction costs of IPO	$ 562,121

Significant Accounting Polici_4

Significant Accounting Policies - Summary of Earnings Per Share, Basic and Diluted (Detail)	3 Months Ended
	Mar. 31, 2021USD ($)$ / sharesshares
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
Interest earned on cash and marketable securities held in Trust Account	$ 334
Less: Interest allocable of to Non-Redeemable Class A Ordinary Shares	(37)
Net income allocable to shares subject to possible redemption	297
Numerator: Net Loss Minus Net Earnings
Net loss	(800,759)
Less: Income attributable to ordinary shares subject to possible redemption	(297)
Non-Redeemable net loss	$ (801,056)
Redeemable Class A Common Stock [Member]
Denominator: Weighted Average Redeemable Class A Ordinary Shares
Basic and diluted weighted average shares outstanding | shares	23,809,201
Basic and diluted net income loss per share | $ / shares	$ 0
Non-redeemable Class A and Class B Common Stock [Member]
Denominator: Weighted Average Redeemable Class A Ordinary Shares
Basic and diluted weighted average shares outstanding | shares	6,434,043
Basic and diluted net income loss per share | $ / shares	$ (0.12)

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail)	Mar. 31, 2021USD ($)shares	Mar. 31, 2021USD ($)
FDIC insured amount	$ 250,000	$ 250,000
Unrecognized tax benefits	0	0
Accrued for interest and penalties	0	0
Offering costs allocated to warrants		618,405
Cash Equivalents	$ 0	0
Over-Allotment Option [Member]
Transaction costs of IPO		15,722,172
Offering costs allocated to warrants		$ 618,405
Warrants issued during period, shares | shares	9,042,843
IPO [Member]
Warrants issued during period, shares | shares	9,042,843
Private Placement Warrant [Member]
Warrants issued during period, shares | shares	(4,950,471)

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)	Mar. 31, 2021	Mar. 23, 2021	Mar. 31, 2021
Stockholders Equity Note [Line Items]
Stock Issued during period, value, new issues			$ 245,503,904
Common Stock, Shares Subscribed but Unissued	3,750,000		3,750,000
Proceeds from issuance of IPO			$ 265,859,614
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Stockholders Equity Note [Line Items]
Share redemption trigger price			$ 18
Class of warrant or right, exercise price adjustment percentage higher of market value	180.00%		180.00%
Share Price Equal or Less Nine point Two Rupees per dollar [Member]
Stockholders Equity Note [Line Items]
Share redemption trigger price			$ 9.20
Class of warrant or right, exercise price adjustment percentage higher of market value	115.00%		115.00%
Public Warrants [Member]
Stockholders Equity Note [Line Items]
Exercise price of warrants or rights	$ 11.50		$ 11.50
Warrants exercisable term from the date of completion of business combination			30 days
Warrants and rights outstanding, term	5 years		5 years
Minimum lock In period For SEC Registration From Date Of Business Combination			30 days
Minimum lock In period to become effective after the closing of the initial Business Combination			60 days
Private Placement Warrants [Member]
Stockholders Equity Note [Line Items]
Exercise price of warrants or rights	$ 10		$ 10
Over-Allotment Option [Member]
Stockholders Equity Note [Line Items]
Stock issued during period shares	2,128,532	3,750,000	2,128,532
Stock Issued during period, value, new issues			$ 21,285,320
Overallotment option vesting period			45 days
Common Class A [Member]
Stockholders Equity Note [Line Items]
Class of warrants, redemption notice period			10 days
Common Class A [Member] | Share Price Equal or Less Nine point Two Rupees per dollar [Member]
Stockholders Equity Note [Line Items]
Exercise price of warrants or rights	$ 9.20		$ 9.20
Share redemption trigger price			10
Minimum Percentage Gross Proceeds Required From Issuance Of Equity	$ 60		$ 60
Class of warrant or right minimum notice period for redemption			20 days
Common Class A [Member] | Public Warrants [Member]
Stockholders Equity Note [Line Items]
Shares issuable per warrant	1	1	1
Exercise price of warrants or rights	$ 11.50	$ 11.50	$ 11.50
Common Class A [Member] | Private Placement Warrants [Member] | Share Price Equal or More Ten point Zero Rupees per dollar [Member]
Stockholders Equity Note [Line Items]
Share price	18		$ 18
Number of consecutive trading days for determining share price			20 days
Number of trading days for determining share price			30 days
Common Class A [Member] | Redemption of warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Stockholders Equity Note [Line Items]
Share price	18		$ 18
Class of warrants, redemption price per unit			$ 0.01
Class of warrants, redemption notice period			30 days
Number of consecutive trading days for determining share price			20 days
Number of trading days for determining share price			30 days
Common Class A [Member] | Redemption of warrants [Member] | Share Price Equal or More Ten point Zero Rupees per dollar [Member]
Stockholders Equity Note [Line Items]
Share price	$ 10		$ 10
Class of warrants, redemption price per unit			$ 0.10
Class of warrants, redemption notice period			30 days
Number of consecutive trading days for determining share price			20 days
Number of trading days for determining share price			30 days
Common Class A [Member] | IPO [Member]
Stockholders Equity Note [Line Items]
Stock issued during period shares		25,000,000
Share price		$ 10
Proceeds from issuance of IPO		$ 250,000,000
Common Class A [Member] | Over-Allotment Option [Member]
Stockholders Equity Note [Line Items]
Overallotment option vesting period		45 days

Private Placement - Additional

Private Placement - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2021USD ($)$ / sharesshares
Proceeds from issuance of private placement	$ 7,425,706
Private Placement Warrants [Member]
Class of warrants and rights issued during the period | shares	4,666,667
Class of warrants and rights issued, price per warrant | $ / shares	$ 1.50
Proceeds from issuance of private placement	$ 7,000,000
Minimum lock In period for transfer, assign or sell warrants after completion of IPO	30 days
Sponsor [Member] | Private Placement Warrants [Member]
Class of warrants and rights issued during the period | shares	283,804
Class of warrants and rights issued, price per warrant | $ / shares	$ 1.50
Proceeds from issuance of private placement	$ 425,706

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Mar. 31, 2021	Mar. 23, 2021	Mar. 15, 2021	Jan. 19, 2021	Mar. 31, 2021
Related Party Transaction [Line Items]
Stock issued during period, value, issued for services					$ 25,000
Proceeds from related party debt					211,135
Due to related party	$ 2,581				$ 2,581
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Stock issued during period shares	2,128,532	3,750,000			2,128,532
Working Capital Loan [Member]
Related Party Transaction [Line Items]
Debt instrument convertible into warrants	$ 1,500,000				$ 1,500,000
Debt instrument conversion price	$ 1.50				$ 1.50
Due to related party	$ 0				$ 0
Sponsor [Member]
Related Party Transaction [Line Items]
Accounts payable, related parties, current	$ 2,581				$ 2,581
Sponsor [Member] | Office Space Administrative And Support Services [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction		$ 10,000
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount				$ 300,000
Proceeds from related party debt		$ 211,135
Founder shares [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Stock repurchased during period, shares					2,128,532
Common Class A [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period shares			6,413,571
Common Class A [Member] | Share Price More Than Or Equals To USD Twelve [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Share transfer, trigger price per share	$ 12				$ 12
Number of consecutive trading days for determining share price					20 days
Number of trading days for determining share price					30 days
Threshold number of trading days for determining share price from date of business combination					150 days
Common Class B [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period shares		6,413,571
Common Class B [Member] | Founder shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period shares				7,187,500
Stock issued during period, value, issued for services				$ 25,000
Shares issued, shares, share-based payment arrangement, forfeited			937,500
Stock repurchased during period, shares					532,132
Common Class B [Member] | Founder shares [Member] | Sponsor [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Shares issued price per share				$ 0.003
Common Class B [Member] | Founder shares [Member] | Sponsor [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Shares issued price per share				$ 0.0001

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Mar. 31, 2021	Mar. 23, 2021	Mar. 15, 2021	Mar. 31, 2021
Commitments And Contingencies [Line Items]
Threshold period for registration statement become effective termination of lock up period of shares after the completion of initial business combination				30 days
Deferred underwriting fee	$ 9,494,986			$ 9,494,986
Common Class A [Member] | Sponsor [Member]
Commitments And Contingencies [Line Items]
Stock issued during period shares			6,413,571
Common Class A [Member] | Share Price More Than Or Equals To USD Twelve [Member] | Sponsor [Member]
Commitments And Contingencies [Line Items]
Share transfer, trigger price per share	$ 12			$ 12
Number of consecutive trading days for determining share price				20 days
Number of trading days for determining share price				30 days
Threshold number of trading days for determining share price from date of business combination				150 days
Over-Allotment Option [Member]
Commitments And Contingencies [Line Items]
Overallotment option vesting period				45 days
Deferred underwriting fee	$ 9,494,986			$ 9,494,986
Stock issued during period shares	2,128,532	3,750,000		2,128,532
Over-Allotment Option [Member] | Common Class A [Member]
Commitments And Contingencies [Line Items]
Overallotment option vesting period		45 days
Underwriting Agreement | Over-Allotment Option [Member]
Commitments And Contingencies [Line Items]
Underwriting discount		$ 5,000,000
Additional underwriting discount				$ 425,706
Percentage of deferred underwriting fee eligible on gross proceeds of the IPO	3.50%			3.50%
Deferred underwriting fee	$ 9,494,986			$ 9,494,986

Shareholders' Equity - Addition

Shareholders' Equity - Additional information (Detail)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Preferred stock shares authorized	5,000,000
Preferred stock shares outstanding	0
Preferred stock shares issued	0
Common stock threshold percentage on conversion of shares	20.00%
Common Class A [Member]
Temporary equity shares outstanding	24,125,995
Common stock par or stated value per share | $ / shares	$ 0.0001
Common stock shares authorized	500,000,000
Common stock shares issued	3,002,537
Common stock shares outstanding	3,002,537
Common Class A [Member] | Common Stock Subject to Mandatory Redemption [Member]
Temporary equity shares outstanding	24,152,438
Common stock shares issued	3,002,537
Common stock shares outstanding	3,002,537
Common Class B [Member]
Common stock par or stated value per share | $ / shares	$ 0.0001
Common stock shares authorized	50,000,000
Common stock shares issued	6,655,368
Common stock shares outstanding	6,655,368
Common stock voting rights	one vote

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Detail)	Mar. 31, 2021USD ($)
Liabilities:
Warrant liability	$ 16,701,548
Fair Value, Recurring
Assets:
Cash	21,285,320
Total value	271,285,654
Liabilities:
Warrant liability	16,701,548
Public Warrants [Member] | Fair Value, Recurring
Liabilities:
Warrant liability	10,760,983
Private Placement Warrants [Member] | Fair Value, Recurring
Liabilities:
Warrant liability	5,940,565
US Money Market [Member] | Fair Value, Recurring
Assets:
Assets	250,000,334
Level 1 [Member] | Fair Value, Recurring
Assets:
Cash	21,285,320
Total value	271,285,654
Level 1 [Member] | US Money Market [Member] | Fair Value, Recurring
Assets:
Assets	250,000,334
Level 3 [Member] | Fair Value, Recurring
Liabilities:
Warrant liability	16,701,548
Level 3 [Member] | Public Warrants [Member] | Fair Value, Recurring
Liabilities:
Warrant liability	10,760,983
Level 3 [Member] | Private Placement Warrants [Member] | Fair Value, Recurring
Liabilities:
Warrant liability	$ 5,940,565

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Change In The Fair Value of The Level 3 Liabilities (Detail) - Level 3 [Member]	3 Months Ended
	Mar. 31, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value at January 15, 2021 (inception)
Initial fair value of public and private warrants	15,386,666
Initial fair value of public and private warrants issued with over-allotment	1,184,882
Change in fair value of public and private warrants	130,000
Fair Value at March 31, 2021	$ 16,701,548

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail)	Mar. 31, 2021sharesyr	Mar. 23, 2021sharesyr
Risk-free interest rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants	1.16	1.06
Expected term remaining (years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants | yr	6	6
Expected volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants	14.8	15
Share price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants | shares	9.56	9.61